GGrantIndex
← Leaderboards

University Of The Pacific-Stockton

Stockton, CA

Compare ↔
$14,356,500
Total funding
33
Grants

Funding over time

peak $1.8M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,356,500 · 33

By mechanism

R15$5,549,205 · 19
R01$3,239,350 · 4
U01$2,264,607 · 1
SC1$1,155,503 · 1
R21$1,034,019 · 3
R16$860,033 · 2

Investigators at University Of The Pacific-Stockton

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Xiaoyuan Han$526,0331 gr2Liang Xue$345,8481 gr3Der Thor$334,0001 gr

Emerging Leaders

6–10 yrs in

1Carlos Alberto Villalba-Galea$723,8132 gr2Douglas Conrad Weiser$305,2161 gr3Andreas H Franz$99,4751 gr

All-Time

Most funded here, all years

1Miriam Gochin$3,067,0737 gr2William K Chan$2,110,7133 gr3Mamoun M Alhamadsheh$1,684,5503 gr4Carlos Alberto Villalba-Galea$723,8132 gr5Leigh Charles Anderson$598,3562 gr6Xiaoyuan Han$526,0331 gr7Xin Guo$498,5632 gr8Roshanak Rahimian$498,0633 gr

Largest grants

Pacific-Stanford PRIMED Program: Training the next generation of clinical oral health researchers$764,646
U01 · FY2023 · DE
Pacific-Stanford PRIMED Program: Training the next generation of clinical oral health researchers$758,372
U01 · FY2025 · DE
Pacific-Stanford PRIMED Program: Training the next generation of clinical oral health researchers$741,589
U01 · FY2024 · DE
Investigating the molecular mechanisms in controlling the aryl hydrocarbon receptor protein levels$382,757
R15 · FY2019 · ES
A new and improved drug delivery system for targeting cancer$372,731
R15 · FY2018 · GM
Investigating the molecular mechanisms in controlling the aryl hydrocarbon recept$367,058
R15 · FY2014 · ES
Identification of Structural Determinants in Kv7 Open Channel Stabilization$359,563
R21 · FY2020 · NS
Assessment of Mechanical Stimulation of Mesenchymally Derived Constructs in an MRI Bioreactor$353,080
R15 · FY2019 · AR
A novel drug delivery system for the prevention and rescue of fentanyl and other opioid overdoses$337,500
R01 · FY2024 · DA
A novel drug delivery system for the prevention and rescue of fentanyl and other opioid overdoses$337,500
R01 · FY2025 · DA
A novel drug delivery system for the prevention and rescue of fentanyl and other opioid overdoses$337,500
R01 · FY2023 · DA
Lipid-coated, pH-sensitive Phosphate Particles for Intracellular Protein Delivery$316,108
R15 · FY2015 · GM
Regulation of the Unfolded Protein Response by eIF2 alpha phosphatases$305,216
R15 · FY2017 · GM
Diabetes, Estrogen and Endothelial Dysfunction$302,438
R15 · FY2016 · HL
Harnessing transthyretin to extend the in vivo half-life of therapeutic peptides$299,319
R15 · FY2014 · GM
Analysis of secretory mechanisms and heterologous proteins in Pichia pastoris$298,426
R15 · FY2018 · GM
Development of flavone- and flavonoid-based DNA triplex specific binding ligands as antigene enhancers$297,332
R15 · FY2022 · GM
GHB Toxicokinetics: Role of sex hormone dependent monocarboxylate transporter regulation and potential for altered overdose risk in transgender men and women$290,624
SC1 · FY2023 · DA
GHB Toxicokinetics: Role of sex hormone dependent monocarboxylate transporter regulation and potential for altered overdose risk in transgender men and women$289,440
SC1 · FY2022 · DA
GHB Toxicokinetics: Role of sex hormone dependent monocarboxylate transporter regulation and potential for altered overdose risk in transgender men and women$288,291
SC1 · FY2021 · DA